Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.3M Buy
80,120
+25,972
+48% +$21.4M 0.33% 61
2026
Q1
$39.5M Buy
54,148
+5,407
+11% +$4.23M 0.21% 110
2025
Q4
$41M Buy
48,741
+541
+1% +$463K 0.2% 111
2025
Q3
$35.6M Buy
48,200
+2,633
+6% +$1.74M 0.19% 120
2025
Q2
$25.1M Buy
45,567
+4,287
+10% +$2.49M 0.14% 136
2025
Q1
$24.4M Sell
41,280
-6,930
-14% -$4.37M 0.15% 138
2024
Q4
$29.6M Sell
48,210
-3,208
-6% -$1.88M 0.17% 119
2024
Q3
$27.9M Hold
51,418
0.16% 134
2024
Q2
$22.1M Buy
51,418
+13,265
+35% +$5.08M 0.13% 151
2024
Q1
$15M Buy
+38,153
New +$14.8M 0.1% 205
2021
Q4
Sell
-49,526
Closed -$15M 803
2021
Q3
$15M Hold
49,526
0.1% 215
2021
Q2
$14.9M Buy
49,526
+10,753
+28% +$3.06M 0.1% 230
2021
Q1
$11M Sell
38,773
-4
-0% -$1.26K 0.09% 237
2020
Q4
$11.4M Sell
38,777
-246
-0.6% -$67.6K 0.09% 241
2020
Q3
$10.2M Sell
39,023
-20,884
-35% -$5.02M 0.1% 226
2020
Q2
$13.5M Buy
59,907
+51,586
+620% +$9.16M 0.14% 169
2020
Q1
$1.3M Buy
8,321
+9
+0.1% +$1.32K 0.01% 610
2019
Q4
$1.33M Buy
+8,312
New +$1.12M 0.01% 626

Other funds holding ARGX

Candriam SCA's ARGX Position: Q2 2026 in Review

Candriam SCA increased its argenx (ARGX) stake by 48% in Q2 2026, buying an estimated $21.4M and bringing the position to 80,120 shares worth $74.3M. The position accounts for 0.33% of the portfolio, ranked #61.

Candriam SCA first reported a position in ARGX in Q4 2019 and has held it in 18 quarters since. 505 funds tracked by Wall St. Rank hold ARGX as of Q2 2026.

  • Candriam SCA held 80,120 shares of argenx worth $74.3M as of Q2 2026.
  • Candriam SCA bought 25,972 argenx shares in Q2 2026, an estimated $21.4M.
  • argenx made up 0.33% of Candriam SCA's portfolio in Q2 2026, its #61 holding.
  • Candriam SCA first reported a position in argenx in Q4 2019 and has held it in 18 quarters since.
  • 505 funds tracked by Wall St. Rank held argenx as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.